Navigation Links
Precyse Secures Healthcare IT Executive Chris Powell as New President
Date:5/10/2011

nhanced services model, including focus on product development and enhancements, engagement in merger and acquisition and channel partnership opportunities.

"The timing of this important appointment could not be better," said Levitt. "The healthcare industry is facing tremendous change, and along with that change are some significant challenges. Precyse is dedicated to continually evolving in order to help our clients meet those challenges head on. The evolution in our new corporate identity and our new technological solution, precyseCode, both reflect the innovation with which we are approaching the management of healthcare information. It is fitting that we appoint someone who has the skills and experience to guide us through this crucial time in our history, Chris Powell is the ideal choice. He brings extensive general management and healthcare IT experience to this role, and also the leadership and management skills required for a cross-functional team such as ours. Throughout his career, he has consistently excelled, meeting or exceeding both professional and company goals. I am very pleased that Chris will be joining us at such an exciting time."

Prior to joining Precyse, Mr. Powell served as Vice President and General Manager of GE Healthcare Americas Commercial Healthcare IT business including the US, Canada, Central and South America, where he was responsible for the operation and execution of the firm's commercial business plan, resulting in generating over $1 billion in revenue. He also managed a complex organizational matrix where he was focused on driving a connected employee culture using a multidimensional and innovative communication strategy. Prior to GE, M
'/>"/>

SOURCE Precyse
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Precyse Solutions and M*Modal Announce Breakthrough CAC Solution
2. Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management
3. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. GeoVax Secures $10 Million Financing Commitment
6. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
7. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
8. ALung Secures $2.5 Million
9. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
10. EnzySurge, Maker of DermaStream(R) Secures US$2.5 Million in Private Capital
11. HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... -- CytRx Corporation (NASDAQ: CYTR ), a ... that data regarding the Company,s Phase 2b global clinical ... tissue sarcoma (STS) will be presented in a moderated ... (CTOS) Annual Meeting which is being held October 15-18, ... the longer than expected survival of patients in the ...
(Date:10/16/2014)...  One of California,s most ... the Patient Advocate — this week recognized Kaiser Permanente,s ... state for the seventh consecutive year. The ... and Kaiser Permanente Southern California are the only health ... a four-star rating — the highest possible — for ...
(Date:10/16/2014)... YORK , Oct. 16, 2014 Curtis ... organizer is under 3 weeks away from hosting their co-located ... and Oral Drug Formulation Innovations Summit taking ... San Diego, CA. November,s ... development organizations in streamlining the bioequivalence testing process, as ...
Breaking Medicine Technology:CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 2CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 3CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 4CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 5CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 6Kaiser Permanente's California Health Plans Rated Highest for Quality for Seventh Consecutive Year 2Kaiser Permanente's California Health Plans Rated Highest for Quality for Seventh Consecutive Year 3Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego 2
... July 14 ERT (Nasdaq: ERES ) announced today that ... August 9, 2010 , after the market closes. After the release, the Company ... , , , ... participants should dial 1-800-860-2442 when calling within the United States or ...
... , HONOLULU , July 14 EnVivo ... on Alzheimer,s Disease (ICAD) results from its proprietary gamma-secretase modulator ... reduced amyloid plaque buildup which is believed to be a ... inflammation associated with Alzheimer,s disease. , ...
Cached Medicine Technology:ERT to Announce Second Quarter 2010 Results on August 9, 2010 2EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimer's Disease 2
(Date:10/20/2014)... Rockynol Retirement Community broke ground ... The $11 million project will include the latest in ... with full-service restaurant style dining. , “We are excited ... Assisted Living apartments,” said Kara Hanzie, Rockynol Executive Director ... of care and this investment is proof of our ...
(Date:10/20/2014)... 20, 2014 Based on a ... only imaging assays capable of determining DNA sequence, ... With these three dimensions of high-resolution data, dGH ... the widest range of disease-causing genetic rearrangements, including ... other genomic tools, including today’s advanced sequencing technologies. ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from ... theme for FCPX filmmakers . , “Fun, cool, and ... Citrus theme” Says Christina Austin, CEO of Pixel Film Studios. ... , Citrus comes with all the tools needed for a ... transitions for added style, a title screen for an introduction, ...
(Date:10/20/2014)... hard to imagine what it’s like to live without shoes, ... it’s a reality. And while new shoes are considered a ... barefoot on rocky terrain or sewage-lined streets just to collect ... , Buckner International's Shoes for Orphan Souls project ... encourage support for Air1 and while also providing new shoes ...
(Date:10/20/2014)... Texas (PRWEB) October 20, 2014 Houston ... to present the key elements of his innovative ... professor to plastic surgery residents and faculty at ... , where he, too, was once a medical student. ... the largest private cosmetic plastic surgery practices in Texas, ...
Breaking Medicine News(10 mins):Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... obstacles, research shows , TUESDAY, Feb. 16 (HealthDay News) ... seek treatment for post-traumatic stress disorder, researchers say. , ... Iraq and Afghanistan wars received diagnoses of post-traumatic stress ... the recommended treatment of 10 to 12 weekly sessions ...
... Gets ... ... 16, 2010 -- BusinessCard2 ™, a web-based personal brand management, marketing, and social ... The competition was established to recognize great work in open/social business and organizational design, ...
... confirm that combination hormone therapy increases the risk of heart ... toward an increased risk of heart disease during the first ... within 10 years of menopause, and a more marked elevation ... 10 years after menopause. Analyses indicate that overall a ...
... Survey found most people thought they were fine, while their ... rising rates of obesity and diabetes, a new survey has ... just fine - it,s everyone else who has the problem. ... people,s health "was going in the wrong direction." In contrast, ...
... ... recorded in global sequence databases is growing exponentially, and legal professionals and scientists doing ... discover IP sequence information across these databases. The free seminar includes lunch and roundtable ... (Vocus) ...
... ... contracted with Atlanta-based Premier Anesthesia to manage the anesthesia services for its hospital and ... ... east Texas, has contracted with Atlanta-based Premier Anesthesia to manage the anesthesia services for ...
Cached Medicine News:Health News:BusinessCard2 Wins Social Business Innovation Award 2Health News:BusinessCard2 Wins Social Business Innovation Award 3Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 2Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 3Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 4Health News:Most Americans Think It's Others Who Are Unhealthy 2Health News:Most Americans Think It's Others Who Are Unhealthy 3Health News:GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases 2Health News:Premier Anesthesia Forges New Partnership with Texas Hospital 2
... fixation. Completely resorbable, it presented surgeons with ... the most thoroughly proven product of its ... with system enhancements that make it even ... system means that application of this proven ...
... The intra-operative MR system ... intra-operative tool for radiologists ... goal of the system ... valuable adjunct to standard ...
... ultrasound A-scan Sonomed-315 is intended for visualization ... detection of midline shifts in the brain, ... and easy to use, the Sonomed-315 offers ... A-scanning mode allows to identify the anatomic ...
... With Plasmaseal's Proteus device the two steps ... is injected into Proteus' single use disposable ... base unit. The operator touches a button, ... is separated by centrifugation. Then the integral ...
Medicine Products: